 "Dr Reddy's acquires 6 OTC brands from Ducere Pharma in US")
Dr Reddy’s Laboratories Ltd has acquired six over-the-counter (OTC) brands in the cough-and-cold, pain, and dermatology categories from the US-based Ducere Pharma. Brands that the company has acquired include including Doan’s, Bufferin, Nupercainal ointment, Cruex nail gel, Comtrex, and Myoflex.
“These legacy products enjoy strong brand equity built over several decades. We are extremely excited to be entering the branded consumer health arena through these brands and embarking upon the next avenue of growth for our OTC business in the US,” explained Alok Sonig, executive vice president and head of Dr Reddy’s in the US
According to Sonig, Dr Reddy’s will build upon the sales and marketing efforts for these brands and continue to focus on their expansion into existing and new market channels. Sonig commends the marketing and brand-building efforts of Ducere Pharma, recognising the organisation’s role in successfully revitalising the brands through improved distribution and promotional efforts.
“We think Dr Reddy’s is well-positioned to continue the successful growth of these brands. We feel confident that our brand-loyal consumers will be well-served by the deal,” said Samuel Hines of Casla Capital Management LLC.
“These legacy products enjoy strong brand equity built over several decades. We are extremely excited to be entering the branded consumer health arena through these brands and embarking upon the next avenue of growth for our OTC business in the US,” explained Alok Sonig, executive vice president and head of Dr Reddy’s in the US
According to Sonig, Dr Reddy’s will build upon the sales and marketing efforts for these brands and continue to focus on their expansion into existing and new market channels. Sonig commends the marketing and brand-building efforts of Ducere Pharma, recognising the organisation’s role in successfully revitalising the brands through improved distribution and promotional efforts.
“We think Dr Reddy’s is well-positioned to continue the successful growth of these brands. We feel confident that our brand-loyal consumers will be well-served by the deal,” said Samuel Hines of Casla Capital Management LLC.